The global biosecurity landscape is changing rapidly. Shifting ecosystems, increased international travel, and the dual-use nature of advanced AI all contribute to a more complex threat environment. But the same AI tools that raise these concerns, their creators argue, can also be turned into powerful defenses.
On July 16, 2026, Google DeepMind and its drug-discovery spinoff Isomorphic Labs published their joint approach to what they call "bioresilience" — a framework for using AI to prevent, detect, and respond to biological threats. The program builds on a foundation of breakthroughs that have already reshaped biology: AlphaFold, which mapped the 3D structures of nearly all known proteins; the Isomorphic Labs Drug Design Engine (IsoDDE), which navigates biological systems with enough precision to design real drug candidates; and AlphaGenome, which sheds light on genome function.
On the prevention side, the team follows a four-step safety process: threat modeling, evaluations, mitigations, and monitoring. In-house biologists and security experts work with external partners to understand potential threats, test models against them, and build safeguards. One notable initiative is adapting SynthID, DeepMind's AI watermarking technology, to biology — potentially allowing DNA synthesis providers to detect whether a genetic sequence was generated by an AI model and flagged as risky.
For detection, the program focuses on making pathogen surveillance faster and cheaper. AlphaEvolve, a Gemini-powered coding agent, optimizes the algorithms used for metagenomic sequencing analysis, helping identify new outbreaks more quickly. AlphaGenome and protein function annotation tools are being explored to characterize novel pathogens from sequence data, identifying patterns that traditional methods might miss.
The response pillar is perhaps the most striking. Isomorphic Labs has established a dedicated unit that can rapidly deploy its drug design engine during novel outbreaks, working with governments and global health authorities to design diagnostic and therapeutic strategies. This unit is designed to address both naturally occurring pandemics and potential risks arising from the misuse of advanced AI — a recognition that the same technology that enables bioresilience could also be misused.
Over the past 12 months, DeepMind and Isomorphic Labs have advanced more than 15 partnerships with government bodies, biosecurity organizations, and research groups. The program is part of a broader approach to managing Chemical, Biological, Radiological, and Nuclear (CBRN) risks, aligned with the Frontier Safety Framework that governs how the company evaluates and mitigates risks from its most capable AI systems.
Knowledge takeaway: Google DeepMind and Isomorphic Labs' bioresilience program uses AI across three fronts — threat prevention via model safety evaluations, outbreak detection via AI-optimized genomic surveillance, and rapid response via AI-driven drug and vaccine design • creating a framework that treats AI as both a potential risk and a critical defense tool.